Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Lomitapide | 182431-12-5 | 99.6% | 693.72 | 200 MG
SDP

Supplier:  Medchemexpress LLC HY14667200MG

Encompass_Preferred

Lomitapide is a potent inhibitor of microsomal triglyceride-transfer protein (MTP) with an IC50 of 8 nM in vitro. Intended for research use only, it undergoes hepatic metabolism via cytochrome P-450 (CYP) isoenzyme 3A4 and interacts with CYP3A4 substrates. It has been shown to reduce plasma concentrations of low-density lipoprotein cholesterol (LDL-C) by more than 50%.

  • Target: microsomal triglyceride-transfer protein (MTP)
  • IC50: 8 nM (MTP) in vitro
  • Metabolism: hepatic metabolism via cytochrome P-450 (CYP) isoenzyme 3A4
  • Bioavailability: 7.1% for the 50-mg capsule
  • Half-life: 39.7 hours
  • Appearance: white to off-white solid
  • Powder storage: -20°C for 3 years, 4°C for 2 years
  • Solvent storage: -80°C for 2 years, -20°C for 1 year

Catalog No. 50-003-63038


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.